USA - NASDAQ:GH - US40131M1099 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to GH. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-30 | BTIG | Maintains | Buy -> Buy |
| 2025-10-30 | UBS | Maintains | Buy -> Buy |
| 2025-10-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-30 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-30 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-25 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-09-25 | TD Cowen | Maintains | Buy -> Buy |
| 2025-09-25 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-09-25 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-25 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2025-09-25 | BTIG | Maintains | Buy -> Buy |
| 2025-09-25 | UBS | Maintains | Buy -> Buy |
| 2025-09-25 | Stifel | Maintains | Buy -> Buy |
| 2025-09-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-22 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-22 | Wells Fargo | Initiate | Overweight |
| 2025-09-04 | BTIG | Maintains | Buy -> Buy |
| 2025-07-31 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-07-31 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-06-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-05-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-05 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-05-01 | UBS | Maintains | Buy -> Buy |
| 2025-05-01 | Stifel | Maintains | Buy -> Buy |
| 2025-05-01 | Barclays | Maintains | Overweight -> Overweight |
34 analysts have analysed GH and the average price target is 69.28 USD. This implies a price decrease of -25.52% is expected in the next year compared to the current price of 93.02.
The consensus rating for GUARDANT HEALTH INC (GH) is 85.8824 / 100 . This indicates that analysts generally have a positive outlook on the stock.